33446327|t|Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
33446327|a|INTRODUCTION: The past two decades have been marked by three epidemics linked to emerging coronaviruses. The COVID-19 pandemic highlighted the existence of neurological manifestations associated with SARS-CoV-2 infection and raised the question of the neuropathogenicity of coronaviruses. The aim of this review was to summarize the current data about neurological manifestations and diseases linked to human coronaviruses. MATERIAL AND METHODS: Articles have been identified by searches of PubMed and Google scholar up to September 25, 2020, using a combination of coronavirus and neurology search terms and adding relevant references in the articles. RESULTS: We found five cohorts providing prevalence data of neurological symptoms among a total of 2533 hospitalized COVID-19 patients, and articles focusing on COVID-19 patients with neurological manifestations including a total of 580 patients. Neurological symptoms involved up to 73% of COVID-19 hospitalized patients, and were mostly headache, myalgias and impaired consciousness. Central nervous system (CNS) manifestations reported in COVID-19 were mostly non-specific encephalopathies that represented between 13% and 40% of all neurological manifestations; post-infectious syndromes including acute demyelinating encephalomyelitis (ADEM, n=13), acute necrotizing encephalopathy (ANE, n=4), Bickerstaff's encephalitis (n=5), generalized myoclonus (n=3) and acute transverse myelitis (n=7); other encephalitis including limbic encephalitis (n=9) and miscellaneous encephalitis with variable radiologic findings (n=26); acute cerebrovascular diseases including ischemic strokes (between 1.3% and 4.7% of COVID-19 patients), hemorrhagic strokes (n=17), cerebral venous thrombosis (n=8) and posterior reversible encephalopathy (n=5). Peripheral nervous system (PNS) manifestations reported in COVID-19 were the following: Guillain-Barre syndrome (n=31) and variants including Miller Fisher syndrome (n=3), polyneuritis cranialis (n=2) and facial diplegia (n=2); isolated oculomotor neuropathy (n=6); critical illness myopathy (n=6). Neuropathological studies in COVID-19 patients demonstrated different patterns of CNS damage, mostly ischemic and hemorrhagic changes with few cases of inflammatory injuries. Only one case suggested SARS-CoV-2 infiltration in endothelial and neural cells. We found 10 case reports or case series describing 22 patients with neurological manifestations associated with other human coronaviruses. Among them we found four MERS patients with ADEM or Bickerstaff's encephalitis, two SARS patients with encephalitis who had a positive SARS-CoV PCR in cerebrospinal fluid, five patients with ischemic strokes associated with SARS, eight MERS patients with critical illness neuromyopathy and one MERS patient with Guillain-Barre Syndrome. An autopsy study on SARS-CoV patients demonstrated the presence of the virus in the brain of eight patients. CONCLUSION: The wide range of neurological manifestations and diseases associated with SARS-CoV-2 is consistent with multiple pathogenic pathways including post-infectious mechanisms, septic-associated encephalopathies, coagulopathy or endothelitis. There was no definite evidence to support direct neuropathogenicity of SARS-CoV-2.
33446327	13	27	manifestations	Disease	MESH:D012877
33446327	44	54	SARS-CoV-2	Species	2697049
33446327	65	78	coronaviruses	Species	
33446327	205	218	coronaviruses	Species	
33446327	224	232	COVID-19	Disease	MESH:D000086382
33446327	284	298	manifestations	Disease	MESH:D012877
33446327	315	335	SARS-CoV-2 infection	Disease	MESH:D000086382
33446327	389	402	coronaviruses	Species	
33446327	480	494	manifestations	Disease	MESH:D012877
33446327	518	537	human coronaviruses	Species	2501931
33446327	681	692	coronavirus	Disease	MESH:D018352
33446327	828	849	neurological symptoms	Disease	MESH:D009461
33446327	885	893	COVID-19	Disease	MESH:D000086382
33446327	894	902	patients	Species	9606
33446327	929	937	COVID-19	Disease	MESH:D000086382
33446327	938	946	patients	Species	9606
33446327	965	979	manifestations	Disease	MESH:D012877
33446327	1005	1013	patients	Species	9606
33446327	1015	1036	Neurological symptoms	Disease	MESH:D009461
33446327	1059	1067	COVID-19	Disease	MESH:D000086382
33446327	1081	1089	patients	Species	9606
33446327	1107	1115	headache	Disease	MESH:D006261
33446327	1117	1125	myalgias	Disease	MESH:D063806
33446327	1130	1152	impaired consciousness	Disease	MESH:D003244
33446327	1154	1176	Central nervous system	Disease	MESH:D002493
33446327	1178	1181	CNS	Disease	MESH:D002493
33446327	1183	1197	manifestations	Disease	MESH:D012877
33446327	1210	1218	COVID-19	Disease	MESH:D000086382
33446327	1244	1260	encephalopathies	Disease	MESH:D001927
33446327	1318	1332	manifestations	Disease	MESH:D012877
33446327	1334	1359	post-infectious syndromes	Disease	MESH:D000094025
33446327	1370	1407	acute demyelinating encephalomyelitis	Disease	MESH:D004684
33446327	1409	1413	ADEM	Disease	MESH:D004684
33446327	1422	1454	acute necrotizing encephalopathy	Disease	OMIM:608033
33446327	1456	1459	ANE	Disease	OMIM:608033
33446327	1467	1493	Bickerstaff's encephalitis	Disease	MESH:D004660
33446327	1513	1522	myoclonus	Disease	MESH:D009207
33446327	1539	1558	transverse myelitis	Disease	MESH:D009188
33446327	1572	1584	encephalitis	Disease	MESH:D004660
33446327	1595	1614	limbic encephalitis	Disease	MESH:D020363
33446327	1639	1651	encephalitis	Disease	MESH:D004660
33446327	1700	1724	cerebrovascular diseases	Disease	MESH:D002561
33446327	1735	1751	ischemic strokes	Disease	MESH:D002544
33446327	1778	1786	COVID-19	Disease	MESH:D000086382
33446327	1787	1795	patients	Species	9606
33446327	1798	1817	hemorrhagic strokes	Disease	MESH:D000083302
33446327	1826	1852	cerebral venous thrombosis	Disease	MESH:D020767
33446327	1863	1898	posterior reversible encephalopathy	Disease	MESH:D054038
33446327	1906	1931	Peripheral nervous system	Disease	MESH:D010523
33446327	1933	1936	PNS	Disease	MESH:D010523
33446327	1938	1952	manifestations	Disease	MESH:D012877
33446327	1965	1973	COVID-19	Disease	MESH:D000086382
33446327	1994	2017	Guillain-Barre syndrome	Disease	MESH:D020275
33446327	2048	2070	Miller Fisher syndrome	Disease	MESH:D019846
33446327	2078	2100	polyneuritis cranialis	Disease	MESH:D009443
33446327	2111	2126	facial diplegia	Disease	MESH:C531747
33446327	2143	2164	oculomotor neuropathy	Disease	MESH:D015840
33446327	2172	2188	critical illness	Disease	MESH:D016638
33446327	2189	2197	myopathy	Disease	MESH:D009135
33446327	2234	2242	COVID-19	Disease	MESH:D000086382
33446327	2243	2251	patients	Species	9606
33446327	2287	2297	CNS damage	Disease	MESH:D002493
33446327	2306	2314	ischemic	Disease	MESH:D002545
33446327	2319	2330	hemorrhagic	Disease	MESH:D006470
33446327	2357	2378	inflammatory injuries	Disease	MESH:D007249
33446327	2404	2414	SARS-CoV-2	Species	2697049
33446327	2515	2523	patients	Species	9606
33446327	2542	2556	manifestations	Disease	MESH:D012877
33446327	2579	2598	human coronaviruses	Species	2501931
33446327	2625	2629	MERS	Disease	MESH:D018352
33446327	2630	2638	patients	Species	9606
33446327	2644	2648	ADEM	Disease	MESH:D004684
33446327	2652	2678	Bickerstaff's encephalitis	Disease	MESH:D004660
33446327	2684	2688	SARS	Disease	MESH:D045169
33446327	2689	2697	patients	Species	9606
33446327	2703	2715	encephalitis	Disease	MESH:D004660
33446327	2735	2743	SARS-CoV	Species	694009
33446327	2777	2785	patients	Species	9606
33446327	2791	2807	ischemic strokes	Disease	MESH:D002544
33446327	2824	2828	SARS	Disease	MESH:D045169
33446327	2836	2840	MERS	Disease	MESH:D018352
33446327	2841	2849	patients	Species	9606
33446327	2855	2871	critical illness	Disease	MESH:D016638
33446327	2872	2885	neuromyopathy	Disease	MESH:C566617
33446327	2894	2898	MERS	Disease	MESH:D018352
33446327	2899	2906	patient	Species	9606
33446327	2912	2935	Guillain-Barre Syndrome	Disease	MESH:D020275
33446327	2957	2965	SARS-CoV	Species	694009
33446327	2966	2974	patients	Species	9606
33446327	3036	3044	patients	Species	9606
33446327	3089	3103	manifestations	Disease	MESH:D012877
33446327	3133	3143	SARS-CoV-2	Species	2697049
33446327	3248	3264	encephalopathies	Disease	MESH:D001927
33446327	3266	3278	coagulopathy	Disease	MESH:D001778
33446327	3282	3294	endothelitis	Disease	
33446327	3367	3377	SARS-CoV-2	Species	2697049

